AI Doctor's helper: ChatGPT-5 tested in ICU to reduce errors
NCT ID NCT07293078
First seen Jan 05, 2026 · Last updated Apr 30, 2026 · Updated 19 times
Summary
This study tests whether a special AI program (ChatGPT-5) can help doctors in the intensive care unit (ICU) make better decisions. About 1000 critically ill adults will be randomly assigned to either standard care or care where doctors receive AI-generated suggestions. The main goal is to see if the AI reduces medical errors, such as missed diagnoses or incorrect treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Framingham Union Hospital/MetroWest Medical Center
Framingham, Massachusetts, 01702, United States
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.